1. Home
  2. PVLA vs AZ Comparison

PVLA vs AZ Comparison

Compare PVLA & AZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PVLA
  • AZ
  • Stock Information
  • Founded
  • PVLA 2015
  • AZ 2018
  • Country
  • PVLA United States
  • AZ Canada
  • Employees
  • PVLA N/A
  • AZ N/A
  • Industry
  • PVLA Biotechnology: Pharmaceutical Preparations
  • AZ Industrial Machinery/Components
  • Sector
  • PVLA Health Care
  • AZ Industrials
  • Exchange
  • PVLA Nasdaq
  • AZ Nasdaq
  • Market Cap
  • PVLA 285.2M
  • AZ 339.2M
  • IPO Year
  • PVLA N/A
  • AZ N/A
  • Fundamental
  • Price
  • PVLA $53.42
  • AZ $9.26
  • Analyst Decision
  • PVLA Strong Buy
  • AZ Strong Buy
  • Analyst Count
  • PVLA 11
  • AZ 1
  • Target Price
  • PVLA $56.64
  • AZ $20.00
  • AVG Volume (30 Days)
  • PVLA 153.4K
  • AZ 179.4K
  • Earning Date
  • PVLA 08-14-2025
  • AZ 08-13-2025
  • Dividend Yield
  • PVLA N/A
  • AZ N/A
  • EPS Growth
  • PVLA N/A
  • AZ N/A
  • EPS
  • PVLA N/A
  • AZ N/A
  • Revenue
  • PVLA N/A
  • AZ $7,489,000.00
  • Revenue This Year
  • PVLA N/A
  • AZ $1,343,857.60
  • Revenue Next Year
  • PVLA N/A
  • AZ N/A
  • P/E Ratio
  • PVLA N/A
  • AZ N/A
  • Revenue Growth
  • PVLA N/A
  • AZ 19.04
  • 52 Week Low
  • PVLA $11.17
  • AZ $1.38
  • 52 Week High
  • PVLA $53.93
  • AZ $12.36
  • Technical
  • Relative Strength Index (RSI)
  • PVLA 85.86
  • AZ 43.56
  • Support Level
  • PVLA $46.08
  • AZ $8.52
  • Resistance Level
  • PVLA $50.22
  • AZ $10.22
  • Average True Range (ATR)
  • PVLA 3.11
  • AZ 0.49
  • MACD
  • PVLA 0.70
  • AZ -0.07
  • Stochastic Oscillator
  • PVLA 97.00
  • AZ 43.60

About PVLA Palvella Therapeutics Inc. Common Stock

Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.

About AZ A2Z Smart Technologies Corp.

A2Z Cust2Mate Solutions Corp is engaged in creating shopping carts. With the help of a user-friendly smart algorithm, touch screen, and other technologies, the company streamlines the retail shopping experience by scanning purchased products and enabling in-cart payment so that customers can simply pick & go, and bypass long cashier checkout lines.

Share on Social Networks: